Strota / SUNPHARMA / Quarterly results

Sun Pharmaceutical Industries Q1 FY27 Results: Revenue, Profit and Share Price Reaction

Sun Pharmaceutical Industries' quarterly results from its filings with NSE, consolidated, with how the share price moved on each announcement.

Q1 FY27 (quarter to 30 Jun 2026): revenue ₹15,300 crore (+10.5% year on year), net profit ₹2,895 crore (+27.0% year on year), EPS ₹12.1. Announced 31 Jul 2026, 6:24 pm IST. The shares fell 1.36% on 3 Aug 2026, 2.96 points worse than the Nifty 50. Next results board meeting: 30 Oct 2026.
Revenue
₹15,300 cr
YoY +10.5% · QoQ +4.7%
Net profit
₹2,895 cr
YoY +27.0% · QoQ +6.7%
EPS (basic)
₹12.1
YoY +27.4%
Share price reaction
-1.4%
3 Aug 2026 · vs Nifty -3.0%

Revenue and net profit by quarter

RevenueNet profit
Q4 FY25 Revenue: ₹12,959 cr Q4 FY25 net profit: ₹2,150 cr Q4 FY25 Q1 FY26 Revenue: ₹13,851 cr Q1 FY26 net profit: ₹2,279 cr Q1 FY26 Q2 FY26 Revenue: ₹14,478 cr Q2 FY26 net profit: ₹3,118 cr Q2 FY26 Q3 FY26 Revenue: ₹15,521 cr Q3 FY26 net profit: ₹3,369 cr Q3 FY26 Q4 FY26 Revenue: ₹14,612 cr Q4 FY26 net profit: ₹2,714 cr Q4 FY26 Q1 FY27 Revenue: ₹15,300 cr Q1 FY27 net profit: ₹2,895 cr Q1 FY27

Every quarter

QuarterAnnouncedRevenueYoYNet profitYoYMarginEPSPrice reaction
Q1 FY2731 Jul 2026, 6:24 pm IST 15,300+10.5%2,895+27.0% 18.9%12.1 -1.4%
Q4 FY2622 May 2026, 6:38 pm IST 14,612+12.8%2,714+26.2% 18.6%11.3 -0.2%
Q3 FY2631 Jan 2026, 5:06 pm IST 15,521—3,369— 21.7%14.0 +2.0%
Q2 FY265 Nov 2025, 7:05 pm IST 14,478—3,118— 21.5%13.0 -0.2%
Q1 FY2631 Jul 2025, 6:43 pm IST 13,851—2,279— 16.5%9.5 -4.5%
Q4 FY2522 May 2025, 8:01 pm IST 12,959—2,150— 16.6%9.0 -2.0%

₹ crore. Consolidated figures; net profit is the share attributable to the company's owners where reported. Margin = net profit ÷ revenue. Year-on-year compares with the same quarter a year earlier.

How SUNPHARMA shares react to results

Across the last 6 results here, the shares rose on 1 and fell on 5. The average move was -1.05%, and the average size of the move either way 1.74%; the biggest was -4.51% after the Q1 FY26 results. In the 2 quarters where profit grew year on year, the shares rose 0 times.

The reaction is the close of the first session that could trade on the news (the announcement day if it came before 3:30 pm, otherwise the next session) against the previous close. A few results don't explain a stock's move; markets also price guidance, commentary and what was expected.

Questions

What were Sun Pharmaceutical Industries' Q1 FY27 results?

For the quarter to 30 Jun 2026, Sun Pharmaceutical Industries reported revenue of ₹15,300 crore (+10.5% year on year) and net profit of ₹2,895 crore (+27.0%), with basic EPS of ₹12.1.

How did Sun Pharmaceutical Industries shares react to the Q1 results?

They fell 1.36% on 3 Aug 2026, the first session that could trade on the results (announced after the close); that was 2.96 points worse than the Nifty 50 that day.

When is Sun Pharmaceutical Industries' next results date?

The board meets on 30 Oct 2026 to consider results, according to the company's intimation to NSE.

Do Sun Pharmaceutical Industries shares usually rise after results?

In the last 6 results here they rose 1 times and fell 5 times, moving 1.74% on average either way.

About this data

From Sun Pharmaceutical Industries' Integrated Filing (Financials) XBRL with NSE, which listed companies use for quarterly results since 2025; announcement times are NSE's broadcast times (IST). Share prices are NSE closing prices. See SUNPHARMA stock page for price, open interest and deals, all results declared this week and the results calendar, and SUNPHARMA dividend history.